Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-202P is a human pseudogene related to U6 small nuclear RNA. U6 snRNA itself is a conserved RNA critical to pre-mRNA splicing as part of the spliceosome[1][3], but this pseudogene version, RNU6-202P, is a non-functional genetic "copy" that does not produce a functional RNA or protein product[2]. Such pseudogenes are often present in the genome but do not participate in biological processes and are not considered drug targets, therapeutic receptors, or enzymes. The naming of RNU6-202P can cause confusion: the functional gene is U6 snRNA, which is vital for splicing, but RNU6-202P itself does not encode any functional molecule[2]. Human genomes often contain numerous U6-related pseudogenes, likely reflecting evolutionary backup mechanisms, but these copies do not participate directly in cellular activities[1]. In summary, RNU6-202P, "RNA, U6 small nuclear 202, pseudogene," is a non-functional copy of the U6 snRNA gene, with no known biological function, disease role, or drug interaction, and is not considered a therapeutic target[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 202, pseudogene (RNU6-202P).